Maxim analyst Jason McCarthy upgraded Dare Bioscience (DARE) to Buy from Hold with an $8 price target
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DARE:
- Daré Bioscience Engages Market with New Presentation
- Daré Bioscience’s Earnings Call: Optimism Amid Challenges
- Daré Bioscience: Strategic Growth and Market Expansion with Upcoming Sildenafil Cream Launch
- Daré Bioscience Announces Q2 2025 Financial Results
- Dare Bioscience, Rosy Wellness launch first phase to support DARE to PLAY